Similar articles

• The effects of priscol (2-benzyl-4,5-imidazoline hydrochloride) in the treatment of peripheral vascular diseases.

  FRANK N, STRAZZA JA Jr, HELSPER JT. FRANK N, et al. Ann Intern Med. 1951 Jul;35(1):19-38. doi: 10.7326/0003-4819-35-1-19. Ann Intern Med. 1951. PMID: 14847446 No abstract available.
• [Contribution to the study of a new sympatholytic substance, benzyl 2-imidazoline hydrochloride, priscol].

  SOLLERO L. SOLLERO L. Rev Med Cir Sao Paulo. 1948 Jan-Feb;56(1-2):9-16. Rev Med Cir Sao Paulo. 1948. PMID: 18874101 Portuguese. No abstract available.
• Detoxification of 2-benzyl-imidazoline hydrochloride (priscol) by incubation with hepatic slices from the rat.

  RICHARDS B, CAMERON A, et al. RICHARDS B, et al. Fed Proc. 1948 Mar;7(1 Pt 1):251. Fed Proc. 1948. PMID: 18861293 No abstract available.
• The pharmacology of benzyl-imidazoline (Priscol).

  AHLQUIST RP, HUGGINS RA, WOODBURY RA. AHLQUIST RP, et al. J Pharmacol Exp Ther. 1947 Mar;89(3):271-88. J Pharmacol Exp Ther. 1947. PMID: 20290430 No abstract available.
• Observations on the effects of benzyl-imidazoline (priscol) in man.

  HENDRIX JP, REARDON MJ, MARZONI FA. HENDRIX JP, et al. Fed Proc. 1947;6(1):338. Fed Proc. 1947. PMID: 20249583 No abstract available.